Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes

27 May 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment
Share to Sarcoma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23708912
DOI: 10.1038/leu.2013.160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromesPMID 23708912Read ↗

Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients.Semantic proximity Read ↗

Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevanceSemantic proximity Read ↗

An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis.Semantic proximity Read ↗

Myeloproliferative neoplasms with a low (<5%) CALR mutation allele burden.Semantic proximity Read ↗

ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden.Semantic proximity Read ↗

Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.Semantic proximity Read ↗

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapySemantic proximity Read ↗

Prognostic impact of RAS-pathway mutations in patients with myelofibrosisSemantic proximity Read ↗

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.Semantic proximity Read ↗

Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes.Semantic proximity Read ↗

The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents.Semantic proximity Read ↗

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.